mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
5e-05 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |